Keywords
Affiliated Institutions
Related Publications
Stroke Symptoms and the Decision to Call for an Ambulance
Background and Purpose— Few acute stroke patients are treated with alteplase, partly because of significant prehospital delays after symptom onset. The aim of this study was to ...
Emergency Medical Service Hospital Prenotification Is Associated With Improved Evaluation and Treatment of Acute Ischemic Stroke
Background— The benefits of intravenous tissue-plasminogen activator (tPA) in acute ischemic stroke are time-dependent. Emergency medical services (EMS) hospital prenotification...
Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)
<h3>Objective.</h3> —To evaluate the efficacy and safety of intravenous thrombolysis using recombinant tissue plasminogen activator (rt-PA) in patients with acute ischemic strok...
Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke
As compared with placebo, intravenous alteplase administered between 3 and 4.5 hours after the onset of symptoms significantly improved clinical outcomes in patients with acute ...
Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008
This article represents the update of the European Stroke Initiative Recommendations for Stroke Management. These guidelines cover both ischaemic stroke and transient ischaemic ...
Publication Info
- Year
- 2007
- Type
- letter
- Volume
- 369
- Issue
- 9558
- Pages
- 249-250
- Citations
- 78
- Access
- Closed
External Links
Social Impact
Social media, news, blog, policy document mentions
Citation Metrics
Cite This
Identifiers
- DOI
- 10.1016/s0140-6736(07)60120-2